Liverpool heart and chest hospital

Liverpool L14 3PE

5 studies enrolling now · 25 studies all time

What they study most

Acute Myocardial Infarction, Antineoplastics Toxicity, Arrhythmia, Ventricular, Atrial Fibrillation, Cancer, Cardiac Toxicity, Cardiotoxicity, Cardiovascular Disease, Cardiovascular Diseases, Cardiovascular Risk Factors, Coronary Artery Disease, Cystic Fibrosis

Studies at this site

• The Oxford Risk Factors And Non-Invasive Imaging Study — Recruiting now
• The STOP-MED CTRCD Trial — Recruiting now
• Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease — Running, not enrolling
• Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• Precise Procedural and PCI Plan (P4) — Running, not enrolling
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Running, not enrolling
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation — Completed
• A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
• Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• A Study Evaluating the Long-term Safety of VX-445 Combination Therapy — Completed
• A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
• A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
• A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F) — Completed
• EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients — Completed
• A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis — Completed
• Acute Study to Collect Electrical Signals From the Heart Using a Special Lead — Completed
• GLOBAL Clinical Study — Status unconfirmed
• ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II — Completed